Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024 Cann Group Cann Group has raised A$8.7 million from 1,385 shareholders through a share purchase plan […]
Emyria selected to join Palantir’s foundry builders program by Martin Lane October 8, 2021April 29, 2024
Company news: Bod Australia; Zelira Therapeutics; Creso Pharma; Emyria; AusCann; Allied Corp by Martin Lane September 23, 2021April 26, 2024
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021April 26, 2024
Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab by Martin Lane August 26, 2021April 26, 2024
Cann Group and Emyria go their separate ways on S3 registration by Martin Lane August 13, 2021April 26, 2024
Company news: Emyria; Medibis; Incannex; Eqalis; Greenfern; Creso Pharma; Highlands Investments by Martin Lane August 12, 2021April 26, 2024
New evidence shows opioid use and pain decline, quality of life goes up after cannabis treatment by Martin Lane June 10, 2021April 26, 2024
Revealed: the studies that show medicinal cannabis could solve the opioid addiction crisis by Martin Lane May 13, 2021April 26, 2024
